Arena Pharmaceuticals, Inc. (ARNA) Announces Third Quarter 2009 Financial Results and Recent Developments
11/10/2009 10:43:27 AM
More...
|
Arena Pharmaceuticals, Inc. (ARNA) to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
11/5/2009 9:21:05 AM
More...
|
New Data From Arena Pharmaceuticals, Inc. (ARNA)'s Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life
10/27/2009 8:56:30 AM
More...
|
Positive Data from Arena Pharmaceuticals, Inc. (ARNA)'s Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
10/26/2009 8:16:16 AM
More...
|
Arena Pharmaceuticals, Inc. (ARNA) to Present at Two Upcoming Investor Conferences
10/22/2009 8:58:02 AM
More...
|
Arena Pharmaceuticals, Inc. (ARNA)'s Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
10/12/2009 8:00:42 AM
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Weight-Loss Trial Met Goals
9/18/2009 6:35:43 AM
More...
|
Arena Pharmaceuticals, Inc. (ARNA) to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
7/30/2009 8:52:47 AM
More...
|
Arena Pharmaceuticals, Inc. (ARNA) to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
7/29/2009 8:49:36 AM
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Announces Pricing of Public Offering of Common Stock
7/8/2009 10:18:30 AM
More...
|
|